A groundbreaking development has emerged from the startup Kindred Companion Sciences with the introduction of the world's first hypoallergenic dogs, beagles named Alfie and Bailey. Utilizing CRISPR-Cas9 gene-editing technology, researchers have successfully disabled the gene responsible for producing the Can f 1 protein, which is commonly linked to allergies in humans. Born in 2024, these puppies are healthy, and the genetic alteration does not affect their other genes. Interestingly, the mutation that prevents the production of Can f 1 occurs naturally, meaning it poses no harm to the dogs themselves. Alfie resides with one of the researchers involved in the project, while Bailey is cared for by the company's founder, geneticist Matt Walker. Walker, who has longed for a dog since childhood, often experienced allergic reactions even around breeds labeled as "hypoallergenic." "It feels just amazing to get to have a dog," Walker expressed. The startup aims to secure regulatory approval to expand the availability of hypoallergenic dogs across various breeds for dog enthusiasts everywhere.
Informational material. 18+.
